+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Multiomics Market - Global Forecast 2026-2032- Product Image
Multiomics Market - Global Forecast 2026-2032- Product Image
Sale

Multiomics Market - Global Forecast 2026-2032

  • Report

  • 188 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 5889740
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Multiomics Market is projected to reach USD 2.93 Billion in 2026. It is expected to continue growing at a CAGR of 12.50%, reaching USD 5.98 Billion by 2032.

Multiomics: Integrating Biological Data for More Complete Insight

Multiomics combines information from multiple biological layers, including genomics, transcriptomics, proteomics, metabolomics, epigenomics, and associated clinical or phenotypic data. Its value lies in connecting molecular measurements that are difficult to interpret independently, supporting a more comprehensive view of disease mechanisms, biological variation, therapeutic response, and patient characteristics. Adoption is shaped by sequencing and mass-spectrometry capabilities, computational infrastructure, data standards, analytical expertise, and access to well-annotated samples.

Multiomics Is Shifting Research From Single-Layer Measurement to Integrated Biology

The field is moving toward integrated workflows that link molecular profiles with clinical records, imaging, longitudinal observations, and functional experiments. This shift increases the importance of interoperable data models, standardized sample handling, reproducible pipelines, and analytical methods that can distinguish biological signal from technical variation. Spatial and single-cell approaches are further changing study design by adding cellular context and location to molecular measurements, while improved automation is helping laboratories manage complex, multi-step processes.

Artificial Intelligence Accelerates Integration, Interpretation, and Prioritization

Artificial intelligence is increasingly used to harmonize heterogeneous datasets, identify molecular patterns, classify cell states, prioritize candidate biomarkers, and support hypothesis generation. Machine learning can help reduce dimensionality and reveal relationships that are difficult to detect with conventional analyses, but its usefulness depends on representative training data, rigorous validation, transparent performance measures, and appropriate handling of batch effects. Leaders should treat AI as an analytical aid rather than a substitute for experimental confirmation, clinical assessment, or governance of sensitive biological data.

Regional Capabilities Differ in Infrastructure, Regulation, and Data Access

North America combines advanced research infrastructure, clinical data resources, and established translational programs, while Europe emphasizes cross-border collaboration, privacy protection, and harmonized research practices. Asia-Pacific benefits from strong sequencing capacity, expanding biomedical investment, and diverse population resources, although data interoperability varies across jurisdictions. Latin America is building capacity through academic networks and public-health research, with sample access and infrastructure remaining important considerations. The Middle East is developing genomics and precision-medicine capabilities through national initiatives, while Africa presents valuable population diversity and urgent health applications alongside persistent constraints in infrastructure, funding, and specialist expertise.

Economic and Political Groupings Shape Collaboration and Standards

ASEAN economies are developing complementary capabilities, but differences in infrastructure and regulation make regional interoperability important. BRICS members contribute substantial population diversity, research capacity, and public-health relevance, while collaboration must address varied data-governance environments. The European Union places strong emphasis on privacy, cross-border data use, and common research infrastructure. G7 members generally provide mature scientific ecosystems and translational networks. GCC countries are investing in genomic medicine and coordinated health-data initiatives, and NATO members can benefit from shared standards and resilient research infrastructure while maintaining careful controls over sensitive biological information.

Country-Level Priorities Reflect Distinct Scientific and Health-System Contexts

Australia has strong capabilities in population research and clinical genomics; Brazil offers substantial biodiversity and population diversity alongside uneven infrastructure. Canada combines research strength with geographically distributed health systems, while China has extensive biomedical capacity and large-scale data resources requiring careful governance. France, Germany, Italy, Spain, and the United Kingdom support advanced academic and clinical research, with European privacy and interoperability requirements influencing implementation. India brings large and diverse populations and growing analytical capacity. Japan and South Korea are strong in technology-enabled biomedical research. Mexico is expanding genomic and public-health applications, while Russia maintains scientific capabilities affected by collaboration and data-access constraints. The United States has broad research, clinical, and computational capacity, with regulatory, privacy, and data-integration considerations shaping adoption.

Leaders Should Build Interoperable, Validated, and Responsible Multiomics Programs

Industry leaders should begin with clearly defined biological or clinical questions and select omics layers that directly address them, rather than accumulating data without an analytical purpose. Investment priorities should include standardized sample workflows, interoperable data architecture, quality-control procedures, secure computing, and multidisciplinary teams spanning biology, statistics, informatics, and clinical practice. Organizations should validate findings across independent cohorts, document model limitations, protect participant privacy, and establish governance for consent, secondary use, and equitable representation. Partnerships with hospitals, research institutions, and public-health programs can improve biological context while reducing duplication and strengthening translational relevance.

Methodology: Evidence-Based Synthesis of Technologies, Applications, and Enabling Conditions

This executive summary uses a structured qualitative assessment of the multiomics landscape. The analysis considers the principal omics modalities, enabling laboratory and computational technologies, research and clinical applications, data-management requirements, artificial-intelligence use cases, regulatory considerations, and geographic differences in capability. Regional, group, and country observations are framed around documented scientific infrastructure, population diversity, health-system context, collaboration patterns, and governance conditions. No market estimates, market shares, forecasts, or company-specific claims are used.

Integrated Data and Responsible Analytics Define the Next Phase of Multiomics

Multiomics is becoming a foundation for understanding complex biology because it connects complementary molecular signals with cellular, clinical, and environmental context. Progress will depend less on generating isolated datasets and more on making them comparable, interpretable, secure, and experimentally useful. Organizations that combine rigorous study design, interoperable infrastructure, validated analytics, and responsible data governance will be best positioned to convert multi-layer biological information into credible research and healthcare insights.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Multiomics Market, by Product Type
7.1. Introduction
7.2. Consumables
7.3. Instruments
7.4. Software and Services
7.4.1. Services
7.4.1.1. Data Analysis
7.4.1.2. Sample Preparation
7.4.2. Software
8. Multiomics Market, by Technology
8.1. Introduction
8.2. Mass Spectrometry
8.3. Microarrays
8.4. qPCR
8.5. Sequencing
8.5.1. Next Generation Sequencing
8.5.2. Sanger Sequencing
9. Multiomics Market, by Application
9.1. Introduction
9.2. Agriculture and Food Testing
9.3. Biomarker Discovery
9.4. Clinical Diagnostics
9.5. Drug Discovery and Development
9.6. Personalized Medicine
10. Multiomics Market, by End User
10.1. Introduction
10.2. Academic and Research Institutes
10.3. Contract Research Organizations
10.4. Hospitals and Diagnostic Laboratories
10.5. Pharmaceutical and Biotechnology Companies
11. Multiomics Market, by Region
11.1. Introduction
11.2. Asia-Pacific
11.3. North America
11.4. Latin America
11.5. Europe
11.6. Middle East
11.7. Africa
12. Multiomics Market, by Group
12.1. Introduction
12.2. ASEAN
12.3. GCC
12.4. European Union
12.5. BRICS
12.6. G7
12.7. NATO
13. Multiomics Market, by Country
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. United Kingdom
13.7. Germany
13.8. France
13.9. Russia
13.10. Italy
13.11. Spain
13.12. China
13.13. India
13.14. Japan
13.15. Australia
13.16. South Korea
14. Competitive Landscape
14.1. Market Share Analysis, 2025
14.2. Market Concentration Analysis, 2025
14.2.1. Concentration Ratio (CR)
14.2.2. Herfindahl Hirschman Index (HHI)
14.3. Recent Developments & Impact Analysis, 2025
14.4. Product Portfolio Analysis, 2025
14.5. Benchmarking Analysis, 2025
15. Company Profiles
15.1. 10x Genomics, Inc.
15.2. Becton, Dickinson and Company
15.3. Berkeley Lights, Inc.
15.4. BGI Genomics Co., Ltd.
15.5. Bio-Rad Laboratories, Inc.
15.6. Bio-Techne Corporation
15.7. Charles River Laboratories International, Inc.
15.8. Danaher Corporation
15.9. Dolomite Bio
15.10. EpiCypher, Inc.
15.11. Illumina, Inc.
15.12. NanoCellect Biomedical, Inc.
15.13. NanoString Technologies, Inc.
15.14. Olink Proteomics AB
15.15. QIAGEN N.V.
15.16. Shimadzu Corporation
15.17. Singleron Biotechnologies GmbH
15.18. Standard BioTools Inc.
15.19. Takara Bio Inc.
15.20. Tempus AI, Inc.
15.21. Thermo Fisher Scientific Inc.
16. Key Experts
LIST OF FIGURES
FIGURE 1. Global Multiomics Market, Years Considered for the Study
FIGURE 2. Global Multiomics Market, Research Design
FIGURE 3. Global Multiomics Market, Research Framework
FIGURE 4. Global Multiomics Market, Data Triangulation
FIGURE 5. Global Multiomics Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Multiomics Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 7. Global Multiomics Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Multiomics Market Size, by Technology, 2025 vs 2032 (%)
FIGURE 9. Global Multiomics Market Size, by Technology, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Multiomics Market Size, by Application, 2025 vs 2032 (%)
FIGURE 11. Global Multiomics Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Multiomics Market Size, by End User, 2025 vs 2032 (%)
FIGURE 13. Global Multiomics Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Multiomics Market Size, by Region, 2025 vs 2032 (%)
FIGURE 15. Global Multiomics Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Multiomics Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 17. Global Multiomics Market Size, by Country, 2025 vs 2032 (%)
FIGURE 18. Global Multiomics Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Multiomics Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Multiomics Market Segmentation & Coverage
TABLE 2. Global Multiomics Market Size, 2017-2032 (USD Million)
TABLE 3. Global Multiomics Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 4. Global Consumables Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Consumables Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Consumables Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Instruments Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Instruments Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Instruments Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Software and Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Software and Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Software and Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Data Analysis Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Data Analysis Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Data Analysis Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Sample Preparation Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Sample Preparation Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Sample Preparation Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Software Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Software Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Software Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Multiomics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 26. Global Mass Spectrometry Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global Mass Spectrometry Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global Mass Spectrometry Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global Microarrays Market Size, by Region, 2017-2032 (USD Million)
TABLE 30. Global Microarrays Market Size, by Group, 2017-2032 (USD Million)
TABLE 31. Global Microarrays Market Size, by Country, 2017-2032 (USD Million)
TABLE 32. Global qPCR Market Size, by Region, 2017-2032 (USD Million)
TABLE 33. Global qPCR Market Size, by Group, 2017-2032 (USD Million)
TABLE 34. Global qPCR Market Size, by Country, 2017-2032 (USD Million)
TABLE 35. Global Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 36. Global Sequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 37. Global Sequencing Market Size, by Country, 2017-2032 (USD Million)
TABLE 38. Global Next Generation Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 39. Global Next Generation Sequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 40. Global Next Generation Sequencing Market Size, by Country, 2017-2032 (USD Million)
TABLE 41. Global Sanger Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 42. Global Sanger Sequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 43. Global Sanger Sequencing Market Size, by Country, 2017-2032 (USD Million)
TABLE 44. Global Multiomics Market Size, by Application, 2017-2032 (USD Million)
TABLE 45. Global Agriculture and Food Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 46. Global Agriculture and Food Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 47. Global Agriculture and Food Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 48. Global Biomarker Discovery Market Size, by Region, 2017-2032 (USD Million)
TABLE 49. Global Biomarker Discovery Market Size, by Group, 2017-2032 (USD Million)
TABLE 50. Global Biomarker Discovery Market Size, by Country, 2017-2032 (USD Million)
TABLE 51. Global Clinical Diagnostics Market Size, by Region, 2017-2032 (USD Million)
TABLE 52. Global Clinical Diagnostics Market Size, by Group, 2017-2032 (USD Million)
TABLE 53. Global Clinical Diagnostics Market Size, by Country, 2017-2032 (USD Million)
TABLE 54. Global Drug Discovery and Development Market Size, by Region, 2017-2032 (USD Million)
TABLE 55. Global Drug Discovery and Development Market Size, by Group, 2017-2032 (USD Million)
TABLE 56. Global Drug Discovery and Development Market Size, by Country, 2017-2032 (USD Million)
TABLE 57. Global Personalized Medicine Market Size, by Region, 2017-2032 (USD Million)
TABLE 58. Global Personalized Medicine Market Size, by Group, 2017-2032 (USD Million)
TABLE 59. Global Personalized Medicine Market Size, by Country, 2017-2032 (USD Million)
TABLE 60. Global Multiomics Market Size, by End User, 2017-2032 (USD Million)
TABLE 61. Global Academic and Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 62. Global Academic and Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 63. Global Academic and Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 64. Global Contract Research Organizations Market Size, by Region, 2017-2032 (USD Million)
TABLE 65. Global Contract Research Organizations Market Size, by Group, 2017-2032 (USD Million)
TABLE 66. Global Contract Research Organizations Market Size, by Country, 2017-2032 (USD Million)
TABLE 67. Global Hospitals and Diagnostic Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 68. Global Hospitals and Diagnostic Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 69. Global Hospitals and Diagnostic Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 70. Global Pharmaceutical and Biotechnology Companies Market Size, by Region, 2017-2032 (USD Million)
TABLE 71. Global Pharmaceutical and Biotechnology Companies Market Size, by Group, 2017-2032 (USD Million)
TABLE 72. Global Pharmaceutical and Biotechnology Companies Market Size, by Country, 2017-2032 (USD Million)
TABLE 73. Global Multiomics Market Size, by Region, 2017-2032 (USD Million)
TABLE 74. Asia-Pacific Multiomics Market Size, by Region, 2017-2032 (USD Million)
TABLE 75. Asia-Pacific Multiomics Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 76. Asia-Pacific Multiomics Market Size, by Software and Services, 2017-2032 (USD Million)
TABLE 77. Asia-Pacific Multiomics Market Size, by Services, 2017-2032 (USD Million)
TABLE 78. Asia-Pacific Multiomics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 79. Asia-Pacific Multiomics Market Size, by Sequencing, 2017-2032 (USD Million)
TABLE 80. Asia-Pacific Multiomics Market Size, by Application, 2017-2032 (USD Million)
TABLE 81. Asia-Pacific Multiomics Market Size, by End User, 2017-2032 (USD Million)
TABLE 82. North America Multiomics Market Size, by Region, 2017-2032 (USD Million)
TABLE 83. North America Multiomics Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 84. North America Multiomics Market Size, by Software and Services, 2017-2032 (USD Million)
TABLE 85. North America Multiomics Market Size, by Services, 2017-2032 (USD Million)
TABLE 86. North America Multiomics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 87. North America Multiomics Market Size, by Sequencing, 2017-2032 (USD Million)
TABLE 88. North America Multiomics Market Size, by Application, 2017-2032 (USD Million)
TABLE 89. North America Multiomics Market Size, by End User, 2017-2032 (USD Million)
TABLE 90. Latin America Multiomics Market Size, by Region, 2017-2032 (USD Million)
TABLE 91. Latin America Multiomics Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 92. Latin America Multiomics Market Size, by Software and Services, 2017-2032 (USD Million)
TABLE 93. Latin America Multiomics Market Size, by Services, 2017-2032 (USD Million)
TABLE 94. Latin America Multiomics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 95. Latin America Multiomics Market Size, by Sequencing, 2017-2032 (USD Million)
TABLE 96. Latin America Multiomics Market Size, by Application, 2017-2032 (USD Million)
TABLE 97. Latin America Multiomics Market Size, by End User, 2017-2032 (USD Million)
TABLE 98. Europe Multiomics Market Size, by Region, 2017-2032 (USD Million)
TABLE 99. Europe Multiomics Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 100. Europe Multiomics Market Size, by Software and Services, 2017-2032 (USD Million)
TABLE 101. Europe Multiomics Market Size, by Services, 2017-2032 (USD Million)
TABLE 102. Europe Multiomics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 103. Europe Multiomics Market Size, by Sequencing, 2017-2032 (USD Million)
TABLE 104. Europe Multiomics Market Size, by Application, 2017-2032 (USD Million)
TABLE 105. Europe Multiomics Market Size, by End User, 2017-2032 (USD Million)
TABLE 106. Middle East Multiomics Market Size, by Region, 2017-2032 (USD Million)
TABLE 107. Middle East Multiomics Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 108. Middle East Multiomics Market Size, by Software and Services, 2017-2032 (USD Million)
TABLE 109. Middle East Multiomics Market Size, by Services, 2017-2032 (USD Million)
TABLE 110. Middle East Multiomics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 111. Middle East Multiomics Market Size, by Sequencing, 2017-2032 (USD Million)
TABLE 112. Middle East Multiomics Market Size, by Application, 2017-2032 (USD Million)
TABLE 113. Middle East Multiomics Market Size, by End User, 2017-2032 (USD Million)
TABLE 114. Africa Multiomics Market Size, by Region, 2017-2032 (USD Million)
TABLE 115. Africa Multiomics Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 116. Africa Multiomics Market Size, by Software and Services, 2017-2032 (USD Million)
TABLE 117. Africa Multiomics Market Size, by Services, 2017-2032 (USD Million)
TABLE 118. Africa Multiomics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 119. Africa Multiomics Market Size, by Sequencing, 2017-2032 (USD Million)
TABLE 120. Africa Multiomics Market Size, by Application, 2017-2032 (USD Million)
TABLE 121. Africa Multiomics Market Size, by End User, 2017-2032 (USD Million)
TABLE 122. Global Multiomics Market Size, by Group, 2017-2032 (USD Million)
TABLE 123. ASEAN Multiomics Market Size, by Group, 2017-2032 (USD Million)
TABLE 124. ASEAN Multiomics Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 125. ASEAN Multiomics Market Size, by Software and Services, 2017-2032 (USD Million)
TABLE 126. ASEAN Multiomics Market Size, by Services, 2017-2032 (USD Million)
TABLE 127. ASEAN Multiomics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 128. ASEAN Multiomics Market Size, by Sequencing, 2017-2032 (USD Million)
TABLE 129. ASEAN Multiomics Market Size, by Application, 2017-2032 (USD Million)
TABLE 130. ASEAN Multiomics Market Size, by End User, 2017-2032 (USD Million)
TABLE 131. GCC Multiomics Market Size, by Group, 2017-2032 (USD Million)
TABLE 132. GCC Multiomics Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 133. GCC Multiomics Market Size, by Software and Services, 2017-2032 (USD Million)
TABLE 134. GCC Multiomics Market Size, by Services, 2017-2032 (USD Million)
TABLE 135. GCC Multiomics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 136. GCC Multiomics Market Size, by Sequencing, 2017-2032 (USD Million)
TABLE 137. GCC Multiomics Market Size, by Application, 2017-2032 (USD Million)
TABLE 138. GCC Multiomics Market Size, by End User, 2017-2032 (USD Million)
TABLE 139. European Union Multiomics Market Size, by Group, 2017-2032 (USD Million)
TABLE 140. European Union Multiomics Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 141. European Union Multiomics Market Size, by Software and Services, 2017-2032 (USD Million)
TABLE 142. European Union Multiomics Market Size, by Services, 2017-2032 (USD Million)
TABLE 143. European Union Multiomics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 144. European Union Multiomics Market Size, by Sequencing, 2017-2032 (USD Million)
TABLE 145. European Union Multiomics Market Size, by Application, 2017-2032 (USD Million)
TABLE 146. European Union Multiomics Market Size, by End User, 2017-2032 (USD Million)
TABLE 147. BRICS Multiomics Market Size, by Group, 2017-2032 (USD Million)
TABLE 148. BRICS Multiomics Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 149. BRICS Multiomics Market Size, by Software and Services, 2017-2032 (USD Million)
TABLE 150. BRICS Multiomics Market Size, by Services, 2017-2032 (USD Million)
TABLE 151. BRICS Multiomics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 152. BRICS Multiomics Market Size, by Sequencing, 2017-2032 (USD Million)
TABLE 153. BRICS Multiomics Market Size, by Application, 2017-2032 (USD Million)
TABLE 154. BRICS Multiomics Market Size, by End User, 2017-2032 (USD Million)
TABLE 155. G7 Multiomics Market Size, by Group, 2017-2032 (USD Million)
TABLE 156. G7 Multiomics Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 157. G7 Multiomics Market Size, by Software and Services, 2017-2032 (USD Million)
TABLE 158. G7 Multiomics Market Size, by Services, 2017-2032 (USD Million)
TABLE 159. G7 Multiomics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 160. G7 Multiomics Market Size, by Sequencing, 2017-2032 (USD Million)
TABLE 161. G7 Multiomics Market Size, by Application, 2017-2032 (USD Million)
TABLE 162. G7 Multiomics Market Size, by End User, 2017-2032 (USD Million)
TABLE 163. NATO Multiomics Market Size, by Group, 2017-2032 (USD Million)
TABLE 164. NATO Multiomics Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 165. NATO Multiomics Market Size, by Software and Services, 2017-2032 (USD Million)
TABLE 166. NATO Multiomics Market Size, by Services, 2017-2032 (USD Million)
TABLE 167. NATO Multiomics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 168. NATO Multiomics Market Size, by Sequencing, 2017-2032 (USD Million)
TABLE 169. NATO Multiomics Market Size, by Application, 2017-2032 (USD Million)
TABLE 170. NATO Multiomics Market Size, by End User, 2017-2032 (USD Million)
TABLE 171. Global Multiomics Market Size, by Country, 2017-2032 (USD Million)
TABLE 172. United States Multiomics Market Size, 2017-2032 (USD Million)
TABLE 173. United States Multiomics Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 174. United States Multiomics Market Size, by Software and Services, 2017-2032 (USD Million)
TABLE 175. United States Multiomics Market Size, by Services, 2017-2032 (USD Million)
TABLE 176. United States Multiomics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 177. United States Multiomics Market Size, by Sequencing, 2017-2032 (USD Million)
TABLE 178. United States Multiomics Market Size, by Application, 2017-2032 (USD Million)
TABLE 179. United States Multiomics Market Size, by End User, 2017-2032 (USD Million)
TABLE 180. Canada Multiomics Market Size, 2017-2032 (USD Million)
TABLE 181. Canada Multiomics Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 182. Canada Multiomics Market Size, by Software and Services, 2017-2032 (USD Million)
TABLE 183. Canada Multiomics Market Size, by Services, 2017-2032 (USD Million)
TABLE 184. Canada Multiomics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 185. Canada Multiomics Market Size, by Sequencing, 2017-2032 (USD Million)
TABLE 186. Canada Multiomics Market Size, by Application, 2017-2032 (USD Million)
TABLE 187. Canada Multiomics Market Size, by End User, 2017-2032 (USD Million)
TABLE 188. Mexico Multiomics Market Size, 2017-2032 (USD Million)
TABLE 189. Mexico Multiomics Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 190. Mexico Multiomics Market Size, by Software and Services, 2017-2032 (USD Million)
TABLE 191. Mexico Multiomics Market Size, by Services, 2017-2032 (USD Million)
TABLE 192. Mexico Multiomics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 193. Mexico Multiomics Market Size, by Sequencing, 2017-2032 (USD Million)
TABLE 194. Mexico Multiomics Market Size, by Application, 2017-2032 (USD Million)
TABLE 195. Mexico Multiomics Market Size, by End User, 2017-2032 (USD Million)
TABLE 196. Brazil Multiomics Market Size, 2017-2032 (USD Million)
TABLE 197. Brazil Multiomics Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 198. Brazil Multiomics Market Size, by Software and Services, 2017-2032 (USD Million)
TABLE 199. Brazil Multiomics Market Size, by Services, 2017-2032 (USD Million)
TABLE 200. Brazil Multiomics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 201. Brazil Multiomics Market Size, by Sequencing, 2017-2032 (USD Million)
TABLE 202. Brazil Multiomics Market Size, by Application, 2017-2032 (USD Million)
TABLE 203. Brazil Multiomics Market Size, by End User, 2017-2032 (USD Million)
TABLE 204. United Kingdom Multiomics Market Size, 2017-2032 (USD Million)
TABLE 205. United Kingdom Multiomics Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 206. United Kingdom Multiomics Market Size, by Software and Services, 2017-2032 (USD Million)
TABLE 207. United Kingdom Multiomics Market Size, by Services, 2017-2032 (USD Million)
TABLE 208. United Kingdom Multiomics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 209. United Kingdom Multiomics Market Size, by Sequencing, 2017-2032 (USD Million)
TABLE 210. United Kingdom Multiomics Market Size, by Application, 2017-2032 (USD Million)
TABLE 211. United Kingdom Multiomics Market Size, by End User, 2017-2032 (USD Million)
TABLE 212. Germany Multiomics Market Size, 2017-2032 (USD Million)
TABLE 213. Germany Multiomics Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 214. Germany Multiomics Market Size, by Software and Services, 2017-2032 (USD Million)
TABLE 215. Germany Multiomics Market Size, by Services, 2017-2032 (USD Million)
TABLE 216. Germany Multiomics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 217. Germany Multiomics Market Size, by Sequencing, 2017-2032 (USD Million)
TABLE 218. Germany Multiomics Market Size, by Application, 2017-2032 (USD Million)
TABLE 219. Germany Multiomics Market Size, by End User, 2017-2032 (USD Million)
TABLE 220. France Multiomics Market Size, 2017-2032 (USD Million)
TABLE 221. France Multiomics Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 222. France Multiomics Market Size, by Software and Services, 2017-2032 (USD Million)
TABLE 223. France Multiomics Market Size, by Services, 2017-2032 (USD Million)
TABLE 224. France Multiomics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 225. France Multiomics Market Size, by Sequencing, 2017-2032 (USD Million)
TABLE 226. France Multiomics Market Size, by Application, 2017-2032 (USD Million)
TABLE 227. France Multiomics Market Size, by End User, 2017-2032 (USD Million)
TABLE 228. Russia Multiomics Market Size, 2017-2032 (USD Million)
TABLE 229. Russia Multiomics Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 230. Russia Multiomics Market Size, by Software and Services, 2017-2032 (USD Million)
TABLE 231. Russia Multiomics Market Size, by Services, 2017-2032 (USD Million)
TABLE 232. Russia Multiomics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 233. Russia Multiomics Market Size, by Sequencing, 2017-2032 (USD Million)
TABLE 234. Russia Multiomics Market Size, by Application, 2017-2032 (USD Million)
TABLE 235. Russia Multiomics Market Size, by End User, 2017-2032 (USD Million)
TABLE 236. Italy Multiomics Market Size, 2017-2032 (USD Million)
TABLE 237. Italy Multiomics Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 238. Italy Multiomics Market Size, by Software and Services, 2017-2032 (USD Million)
TABLE 239. Italy Multiomics Market Size, by Services, 2017-2032 (USD Million)
TABLE 240. Italy Multiomics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 241. Italy Multiomics Market Size, by Sequencing, 2017-2032 (USD Million)
TABLE 242. Italy Multiomics Market Size, by Application, 2017-2032 (USD Million)
TABLE 243. Italy Multiomics Market Size, by End User, 2017-2032 (USD Million)
TABLE 244. Spain Multiomics Market Size, 2017-2032 (USD Million)
TABLE 245. Spain Multiomics Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 246. Spain Multiomics Market Size, by Software and Services, 2017-2032 (USD Million)
TABLE 247. Spain Multiomics Market Size, by Services, 2017-2032 (USD Million)
TABLE 248. Spain Multiomics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 249. Spain Multiomics Market Size, by Sequencing, 2017-2032 (USD Million)
TABLE 250. Spain Multiomics Market Size, by Application, 2017-2032 (USD Million)
TABLE 251. Spain Multiomics Market Size, by End User, 2017-2032 (USD Million)
TABLE 252. China Multiomics Market Size, 2017-2032 (USD Million)
TABLE 253. China Multiomics Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 254. China Multiomics Market Size, by Software and Services, 2017-2032 (USD Million)
TABLE 255. China Multiomics Market Size, by Services, 2017-2032 (USD Million)
TABLE 256. China Multiomics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 257. China Multiomics Market Size, by Sequencing, 2017-2032 (USD Million)
TABLE 258. China Multiomics Market Size, by Application, 2017-2032 (USD Million)
TABLE 259. China Multiomics Market Size, by End User, 2017-2032 (USD Million)
TABLE 260. India Multiomics Market Size, 2017-2032 (USD Million)
TABLE 261. India Multiomics Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 262. India Multiomics Market Size, by Software and Services, 2017-2032 (USD Million)
TABLE 263. India Multiomics Market Size, by Services, 2017-2032 (USD Million)
TABLE 264. India Multiomics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 265. India Multiomics Market Size, by Sequencing, 2017-2032 (USD Million)
TABLE 266. India Multiomics Market Size, by Application, 2017-2032 (USD Million)
TABLE 267. India Multiomics Market Size, by End User, 2017-2032 (USD Million)
TABLE 268. Japan Multiomics Market Size, 2017-2032 (USD Million)
TABLE 269. Japan Multiomics Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 270. Japan Multiomics Market Size, by Software and Services, 2017-2032 (USD Million)
TABLE 271. Japan Multiomics Market Size, by Services, 2017-2032 (USD Million)
TABLE 272. Japan Multiomics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 273. Japan Multiomics Market Size, by Sequencing, 2017-2032 (USD Million)
TABLE 274. Japan Multiomics Market Size, by Application, 2017-2032 (USD Million)
TABLE 275. Japan Multiomics Market Size, by End User, 2017-2032 (USD Million)
TABLE 276. Australia Multiomics Market Size, 2017-2032 (USD Million)
TABLE 277. Australia Multiomics Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 278. Australia Multiomics Market Size, by Software and Services, 2017-2032 (USD Million)
TABLE 279. Australia Multiomics Market Size, by Services, 2017-2032 (USD Million)
TABLE 280. Australia Multiomics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 281. Australia Multiomics Market Size, by Sequencing, 2017-2032 (USD Million)
TABLE 282. Australia Multiomics Market Size, by Application, 2017-2032 (USD Million)
TABLE 283. Australia Multiomics Market Size, by End User, 2017-2032 (USD Million)
TABLE 284. South Korea Multiomics Market Size, 2017-2032 (USD Million)
TABLE 285. South Korea Multiomics Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 286. South Korea Multiomics Market Size, by Software and Services, 2017-2032 (USD Million)
TABLE 287. South Korea Multiomics Market Size, by Services, 2017-2032 (USD Million)
TABLE 288. South Korea Multiomics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 289. South Korea Multiomics Market Size, by Sequencing, 2017-2032 (USD Million)
TABLE 290. South Korea Multiomics Market Size, by Application, 2017-2032 (USD Million)
TABLE 291. South Korea Multiomics Market Size, by End User, 2017-2032 (USD Million)
TABLE 292. Global Multiomics Market Share, by Key Player, 2025
TABLE 293. Global Multiomics Market, Key Experts

Companies Mentioned

  • 10x Genomics, Inc.
  • Becton, Dickinson and Company
  • Berkeley Lights, Inc.
  • BGI Genomics Co., Ltd.
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Corporation
  • Charles River Laboratories International, Inc.
  • Danaher Corporation
  • Dolomite Bio
  • EpiCypher, Inc.
  • Illumina, Inc.
  • NanoCellect Biomedical, Inc.
  • NanoString Technologies, Inc.
  • Olink Proteomics AB
  • QIAGEN N.V.
  • Shimadzu Corporation
  • Singleron Biotechnologies GmbH
  • Standard BioTools Inc.
  • Takara Bio Inc.
  • Tempus AI, Inc.
  • Thermo Fisher Scientific Inc.

Related Topics

Related Reports

Multiomics Market by Offerings, Method, Technology, Workflow, Application, Competition - Global Forecast to 2031 - Product Image

Multiomics Market by Offerings, Method, Technology, Workflow, Application, Competition - Global Forecast to 2031

  • Report
  • 578 Pages
  • Global
From
Multiomics Market - A Global and Regional Analysis: Focus on Offering, Technology, Approach Type, Omics, Application, Sample Type, End User, 2026-2036 - Product Image

Multiomics Market - A Global and Regional Analysis: Focus on Offering, Technology, Approach Type, Omics, Application, Sample Type, End User, 2026-2036

  • Report
  • 248 Pages
  • Global
From
Single Cell Multiomics Market Report by Type, Product Type, Technique, Application, End User, and Region 2026-2034 - Product Image

Single Cell Multiomics Market Report by Type, Product Type, Technique, Application, End User, and Region 2026-2034

  • Report
  • 140 Pages
  • Global
From
Single Cell Multiomics Market Outlook 2026-2034: Market Share, and Growth Analysis by Product, Technology, Omics Modality, Application - Product Image

Single Cell Multiomics Market Outlook 2026-2034: Market Share, and Growth Analysis by Product, Technology, Omics Modality, Application

  • Report
  • 160 Pages
  • Global
From
Multiomics - Global Strategic Business Report - Product Image

Multiomics - Global Strategic Business Report

  • Report
  • 209 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.